logo

VYNE

VYNEยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

VYNE Profile

Vyne Therapeutics Inc.

A clinical stage bio-pharmaceutical company that developing medicines for chronic pruritus and cough

Pharmaceutical
--
01/25/2018
NASDAQ Stock Exchange
13
12-31
Common stock
685 Route 202/206 N., Suite 301, Bridgewater, New Jersey 08807
--
VYNE Therapeutics Inc., founded in October 2011, is a Delaware corporation named Tigercat Pharma, Inc. The Company is a clinical-stage biopharmaceutical company focused on the development of proprietary, innovative and differentiated therapies for the treatment of immune inflammatory diseases.